Finance

Lists
003020:SHE
Hefei Lifeon Pharmaceutical Co Ltd
CN¥16,31
-0,31%
(-0,050) 1D
15 Okt., 15:04:30 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 003020...
Open
CN¥16,20
High
CN¥16,57
Low
CN¥16,05
Mkt. cap
3,80 mjd
Avg. vol.
3,61 m
Volume
2,65 m
Dividend
2,55%
Quarterly dividend
CN¥0,10
Ex-dividend date
29 Mei 2026
P/E ratio
22,79
52-wk high
CN¥27,01
52-wk low
CN¥14,20
EPS
CN¥0,72
Shares outstanding
228,22 m
No. of employees
1 k
Open
CN¥16,20
High
CN¥16,57
Low
CN¥16,05
Mkt. cap
3,80 mjd
Avg. vol.
3,61 m
Volume
2,65 m
Dividend
2,55%
Quarterly dividend
CN¥0,10
Ex-dividend date
29 Mei 2026
P/E ratio
22,79
52-wk high
CN¥27,01
52-wk low
CN¥14,20
EPS
CN¥0,72
Shares outstanding
228,22 m
No. of employees
1 k
News stories
From web sources and news partners
About Hefei Lifeon Pharmaceutical Co Ltd
CEO-
Employees1,46 k
Founded16 Jul. 2002
Headquarters-
SectorPharmaceutical industry
Websitelifeon.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
348,25 m
473,12 m
357,10 m
327,16 m
Cost of goods sold
112,98 m
179,98 m
121,91 m
110,48 m
Cost of revenue
112,98 m
179,98 m
121,91 m
110,48 m
Research and development expenses
19,45 m
39,36 m
18,38 m
24,73 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
171,75 m
215,72 m
170,83 m
137,12 m
Operating expense
195,72 m
262,92 m
193,88 m
169,72 m
Total operating expenses
308,69 m
442,90 m
315,80 m
280,20 m
Operating income
39,55 m
30,22 m
41,30 m
46,96 m
Other non operating income
-544,58 k
604,09 k
-537,41 k
412,91 k
EBT including unusual items
35,98 m
44,93 m
41,31 m
54,17 m
EBT excluding unusual items
40,71 m
30,20 m
40,63 m
50,19 m
Income tax expense
4,40 m
4,49 m
6,05 m
4,34 m
Effective tax rate
12,23%
10,00%
14,65%
8,01%
Other operating expenses
5,15 m
7,85 m
4,63 m
6,22 m
Net income
30,71 m
44,25 m
35,29 m
52,91 m
Net profit margin
8,82%
9,35%
9,88%
16,17%
Earnings per share
-
-
-
-
Interest and investment income
1,69 m
692,37 k
264,54 k
3,60 m
Interest expense
-
-1,26 m
-399,14 k
-685,13 k
Net interest expenses
1,69 m
-564,11 k
-134,59 k
2,91 m
Depreciation and amortization charges
-
-
-
-
EBITDA
58,28 m
51,18 m
62,27 m
69,21 m
Gain or loss from assets sale
1,77 k
1,68 k
-
-49,79 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme